A Clinical study to which Anti-emetic effect of change of 5-HT3RA is evaluated by using MAT in MEC for gastrointestinal cancer.
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: The aloxi 0.75mg is administered before the anti-cancer drug of day1 is administered. Primary outcome(s): The level of each observation point of the nausea and vomiting before and after 5- HT3RA change is evaluated by MAT. Study Design: Single arm Non-randomized
创建时间：
2010-10-15
